PKD1 and pancreatic neoplasm: These outcomes indicate that expression of PKD1 in pancreatic cancer cells results in chemo-resistance, which attributes to the deregulated glucose metabolism, and its suppression sensitises gemcitabine in pancreatic cancer cells (Fig. 6f).